Sonnet BioTherapeutics Pivots Into Crypto With $888M Hyperliquid Treasury Strategy
Nasdaq-listed biotech firm Sonnet BioTherapeutics is making a bold move into the digital asset space, unveiling plans to launch an $888 million Hyperliquid (HYPE) token treasury under a newly formed entity. On Monday, Sonnet announced it had entered into a business combination with Rorschach, a company it recently created, to ...
